Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.69 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.57 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.57 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.54 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9859814 | 1.00 | MAPT (0.69) | MAPTRXFP1HDAC1HDAC2HDAC3 | |
| SCHEMBL16136610 | 1.00 | MAPT (0.69) | MAPTRXFP1HDAC1HDAC2HDAC3 | |
| SCHEMBL25176127 | 1.00 | MAPT (0.69) | MAPTRXFP1HDAC1HDAC2HDAC3 | |
| SCHEMBL29831093 | 1.00 | MAPT (0.69) | MAPTRXFP1HDAC1HDAC2HDAC3 | |
| SCHEMBL1114650 | 0.98 | MAPT (0.66) | MAPTRXFP1HDAC1HDAC2HDAC3 | |
| SCHEMBL1857558 | 0.92 | HDAC1 (0.67) | MAPTRXFP1HDAC1HDAC2HDAC3 | |
| Hydrochloric Acid SCHEMBL3866368 | 0.90 | SMN1; SMN2 (0.64) | MAPTRXFP1HDAC1HDAC2HDAC3 | |
| SCHEMBL3814880 | 0.90 | MAPT (0.83) | MAPTRXFP1HDAC1HDAC2HDAC3 | |
| SCHEMBL9671779 | 0.90 | MAPT (0.83) | MAPTRXFP1HDAC1HDAC2HDAC3 | |
| SCHEMBL7827144 | 0.88 | MAPT (0.80) | MAPTRXFP1HDAC1HDAC2HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10654880-B2 | Methods for preparation of glycosphingolipids and uses thereof | LIANG PI HUI (TW) | 2020-05-19 | — | — | US | disclosed |
| US-10654880-B2 | Methods for preparation of glycosphingolipids and uses thereof | LIANG PI HUI (TW) | 2020-05-19 | — | — | US | disclosed |
| EP-2661440-B1 | METHOD FOR THE PREPARATION OF GLYCOSPHINGOLIPIDS | UNIV NAT TAIWAN (TW) | 2017-09-27 | — | — | EP | disclosed |
| EP-2661440-B1 | METHOD FOR THE PREPARATION OF GLYCOSPHINGOLIPIDS | UNIV NAT TAIWAN (TW) | 2017-09-27 | — | — | EP | disclosed |
| US-20160229881-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | LIANG PI-HUI (TW) | 2016-08-11 | — | — | US | disclosed |
| US-20160229881-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | LIANG PI-HUI (TW) | 2016-08-11 | — | — | US | disclosed |
| US-20160229881-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | LIANG PI-HUI (TW) | 2016-08-11 | — | — | US | disclosed |
| US-9181292-B2 | Methods for preparation of glycosphingolipids and uses thereof | LIANG PI-HUI (TW) | 2015-11-10 | — | — | US | disclosed |
| US-9181292-B2 | Methods for preparation of glycosphingolipids and uses thereof | LIANG PI-HUI (TW) | 2015-11-10 | — | — | US | disclosed |
| US-9181292-B2 | Methods for preparation of glycosphingolipids and uses thereof | LIANG PI-HUI (TW) | 2015-11-10 | — | — | US | disclosed |
| EP-2661440-A2 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | National Taiwan University (TW) | 2013-11-13 | — | — | EP | disclosed |
| US-20120178705-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-07-12 | — | — | US | disclosed |
| US-20120178705-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-07-12 | — | — | US | disclosed |
| US-20120178705-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-07-12 | — | — | US | disclosed |
| WO-2012094540-A2 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-07-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178705-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | UGCG, CERS2, SGMS1 | MAPT 2929/4885RXFP1 4469/4885HDAC1 1434/4885 |
| US-20160229881-A1 | METHODS FOR PREPARATION OF GLYCOSPHINGOLIPIDS AND USES THEREOF | UGCG, CERS2, SGMS1 | MAPT 2929/4885RXFP1 4469/4885HDAC1 1434/4885 |
| US-10654880-B2 | Methods for preparation of glycosphingolipids and uses thereof | UGCG, CERS2, SGMS1 | MAPT 2929/4885RXFP1 4469/4885HDAC1 1434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.